169 related articles for article (PubMed ID: 19621435)
1. VEGF expression as a prognostic marker in osteosarcoma.
Bajpai J; Sharma M; Sreenivas V; Kumar R; Gamnagatti S; Khan SA; Rastogi S; Malhotra A; Bakhshi S
Pediatr Blood Cancer; 2009 Dec; 53(6):1035-9. PubMed ID: 19621435
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive imaging surrogate of angiogenesis in osteosarcoma.
Bajpai J; Gamanagatti S; Sharma MC; Kumar R; Vishnubhatla S; Khan SA; Rastogi S; Malhotra A; Bakhshi S
Pediatr Blood Cancer; 2010 Apr; 54(4):526-31. PubMed ID: 19890899
[TBL] [Abstract][Full Text] [Related]
3. Does the degree of intratumoural microvessel density and VEGF expression have prognostic significance in osteosarcoma?
Ek ET; Ojaimi J; Kitagawa Y; Choong PF
Oncol Rep; 2006 Jul; 16(1):17-23. PubMed ID: 16786118
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of alpha V integrin and VEGF in osteosarcoma after chemotherapy.
Huang Y; Lin Z; Zhuang J; Chen Y; Lin J
Onkologie; 2008 Oct; 31(10):535-40. PubMed ID: 18854653
[TBL] [Abstract][Full Text] [Related]
5. Prediction of chemotherapy response by PET-CT in osteosarcoma: correlation with histologic necrosis.
Bajpai J; Kumar R; Sreenivas V; Sharma MC; Khan SA; Rastogi S; Malhotra A; Gamnagatti S; Kumar R; Safaya R; Bakhshi S
J Pediatr Hematol Oncol; 2011 Oct; 33(7):e271-8. PubMed ID: 22193290
[TBL] [Abstract][Full Text] [Related]
6. Plasma level and tissue expression of vascular endothelial growth factor in renal cell carcinoma: a prospective study of 50 cases.
Rioux-Leclercq N; Fergelot P; Zerrouki S; Leray E; Jouan F; Bellaud P; Epstein JI; Patard JJ
Hum Pathol; 2007 Oct; 38(10):1489-95. PubMed ID: 17597181
[TBL] [Abstract][Full Text] [Related]
7. [Relationship between vascular endothelial growth factor expression and angiogenesis in osteosarcoma].
Zhao Y; Qiu GX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Dec; 23(6):619-22. PubMed ID: 12901110
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of immunohistochemical expression of ezrin in non-metastatic high-grade osteosarcoma.
Ferrari S; Zanella L; Alberghini M; Palmerini E; Staals E; Bacchini P
Pediatr Blood Cancer; 2008 Apr; 50(4):752-6. PubMed ID: 17886294
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor receptor expression as a prognostic marker for survival in colorectal cancer.
Okita NT; Yamada Y; Takahari D; Hirashima Y; Matsubara J; Kato K; Hamaguchi T; Shirao K; Shimada Y; Taniguchi H; Shimoda T
Jpn J Clin Oncol; 2009 Sep; 39(9):595-600. PubMed ID: 19535387
[TBL] [Abstract][Full Text] [Related]
10. Expression of VEGF-C correlates with a poor prognosis based on analysis of prognostic factors in 73 patients with esophageal squamous cell carcinomas.
Liu P; Chen W; Zhu H; Liu B; Song S; Shen W; Wang F; Tucker S; Zhong B; Wang D
Jpn J Clin Oncol; 2009 Oct; 39(10):644-50. PubMed ID: 19648590
[TBL] [Abstract][Full Text] [Related]
11. VEGF-A and i-NOS expression are prognostic factors in serous epithelial ovarian carcinomas after complete surgical resection.
Engels K; du Bois A; Harter P; Fisseler-Eckhoff A; Kommoss F; Stauber R; Kaufmann M; Nekljudova V; Loibl S
J Clin Pathol; 2009 May; 62(5):448-54. PubMed ID: 19126566
[TBL] [Abstract][Full Text] [Related]
12. VEGF and EMMPRIN expression correlates with survival of patients with osteosarcoma.
Zhou Q; Zhu Y; Deng Z; Long H; Zhang S; Chen X
Surg Oncol; 2011 Mar; 20(1):13-9. PubMed ID: 19836228
[TBL] [Abstract][Full Text] [Related]
13. Anti-angiogenic factor endostatin in osteosarcoma.
Kim HS; Lim SJ; Park YK
APMIS; 2009 Oct; 117(10):716-23. PubMed ID: 19775339
[TBL] [Abstract][Full Text] [Related]
14. Chromogranin A-, serotonin-, synaptophysin- and vascular endothelial growth factor-positive endocrine cells and the prognosis of colorectal cancer: an immunohistochemical and ultrastructural study.
Gulubova M; Vlaykova T
J Gastroenterol Hepatol; 2008 Oct; 23(10):1574-85. PubMed ID: 18771509
[TBL] [Abstract][Full Text] [Related]
15. Expression of estrogen receptor, progesterone receptor, and vascular endothelial growth factor-A in thyroid cancer.
Kansakar E; Chang YJ; Mehrabi M; Mittal V
Am Surg; 2009 Sep; 75(9):785-9; discussion 789. PubMed ID: 19774949
[TBL] [Abstract][Full Text] [Related]
16. Tissue necrosis after chemotherapy in osteosarcoma as the important prognostic factor.
Sami SH; Rafati AH; Hodjat P
Saudi Med J; 2008 Aug; 29(8):1124-9. PubMed ID: 18690304
[TBL] [Abstract][Full Text] [Related]
17. VEGF expression in residual tumor cells in orbital retinoblastoma (IRSS stage III) treated with NACT: a prospective study.
Radhakrishnan V; Kashyap S; Singh L; Bakhshi S
Pediatr Blood Cancer; 2012 Sep; 59(3):567-9. PubMed ID: 22086846
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis rate adjusted by tumor volume change is a better predictor of survival of localized osteosarcoma patients.
Kim MS; Lee SY; Cho WH; Song WS; Koh JS; Lee JA; Yoo JY; Jeon DG
Ann Surg Oncol; 2008 Mar; 15(3):906-14. PubMed ID: 18163171
[TBL] [Abstract][Full Text] [Related]
19. C-erbB-2 expression and prognostic significance in osteosarcoma.
Yalçin B; Gedikoğlu G; Kutluk T; Varan A; Akyüz C; Büyükpamukçu M
Pediatr Blood Cancer; 2008 Aug; 51(2):222-7. PubMed ID: 18421709
[TBL] [Abstract][Full Text] [Related]
20. CD9 expression is not a prognostic factor in human osteosarcoma.
Kubista B; Erovic BM; Klinger H; Sulzbacher I; Trieb K
Cancer Lett; 2004 Jun; 209(1):105-10. PubMed ID: 15145525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
